Summary
Axon Enterprise, Inc. reported strong revenue growth of 33.4% to $2.1 billion for the year ended December 31, 2024. This growth was driven by significant increases in both the TASER segment and the Software and Sensors segment, with notable contributions from TASER device and cartridge sales, as well as Axon Evidence and cloud services. Despite the revenue increase, the company's income from operations decreased to $58.5 million from $156.9 million in the prior year, primarily due to a substantial rise in operating expenses, particularly stock-based compensation and professional/consulting fees related to acquisitions. The company also disclosed two material weaknesses in its internal controls over financial reporting: one related to revenue recognition and another concerning the balance sheet presentation of its convertible senior notes. These weaknesses have led to restatements of prior financial periods. Axon continues to invest heavily in research and development, with R&D expenses increasing by 45.4% year-over-year. The company ended the year with a strong liquidity position, although cash and cash equivalents decreased due to acquisition activities.
Financial Highlights
54 data points| Revenue | $2.08B |
| Cost of Revenue | $841.15M |
| Gross Profit | $1.24B |
| R&D Expenses | $441.59M |
| SG&A Expenses | $741.25M |
| Operating Expenses | $1.18B |
| Operating Income | $58.54M |
| Net Income | $377.03M |
| EPS (Basic) | $4.98 |
| EPS (Diluted) | $4.80 |
| Shares Outstanding (Basic) | 75.75M |
| Shares Outstanding (Diluted) | 78.56M |
Key Highlights
- 1Revenue increased by 33.4% to $2.1 billion for the year ended December 31, 2024, driven by growth in both TASER and Software & Sensors segments.
- 2Income from operations decreased significantly to $58.5 million due to a substantial increase in operating expenses, notably stock-based compensation and acquisition-related costs.
- 3The company reported two material weaknesses in internal control over financial reporting related to revenue recognition and convertible note presentation, necessitating restatements of prior financial periods.
- 4Research and Development (R&D) expenses rose by 45.4% to $441.6 million, reflecting continued investment in innovation.
- 5Axon completed two significant acquisitions in 2024: Fusus and Dedrone, integrating them into its Software and Sensors segment to enhance its public safety technology ecosystem.
- 6The company's liquidity remains strong, with $454.8 million in cash and cash equivalents and available-for-sale investments as of December 31, 2024, though this reflects a decrease from the prior year due to acquisition activities.
- 7Gross margin decreased to 59.6% from 61.2% year-over-year, primarily impacted by increased stock-based compensation and amortization of acquired intangibles.